The headlines of Master Doctor
Clinical Trial Begins for Mix-and-Match of Covid Vaccine Boosters
Clinical trial to test mix-and-match of Covid vaccine boosters has begun by the US researchers. This research will help us understand if adults who have been fully vaccinated...
Enterprise Therapeutics doses first subjects in Phase I trial for novel...
Enterprise Therapeutics Ltd today announced it has successfully dosed the first subjects in a Phase 1 trial for its novel inhaled cystic fibrosis therapy, ETD001.
Missing link in Sydney's light rail back on track
The second stage of the Parramatta Light Rail has been resurrected, with the NSW Government set to allocate $50 million to the project.
Housing reform must address affordability concerns
The Berejiklian government is proposing to reform stamp duty as a way of addressing the problem of housing affordability.
Is there hope for the Bulldogs? Consultant Hansen arrives to see rare...
The legendary All Blacks coach made his first visit to Sydney after being named as a consultant to Trent Barrett - and the Bulldogs promptly belted St George Illawarra.
Torres Strait lodge complaint with the UN against Australian Government
A group called the Torres Strait 8 have lodged a complaint with the United Nations against the Australian Government.
PEXA float a big test for Macquarie after IPO flops
The biggest float in years on the ASX has kicked off with the release of online property conveyancer PEXA's prospectus.
Tough Guy threatens to take shine off Gem's campaign
The campaign of one of the quickest country-based sprinters in NSW goes on the line at Tuesday's feature Scone meeting.
‘I don't see any reason': Investors sleeping on emerging markets boom
Asset managers are tipping local portfolios to increasingly feature companies from so-called developing nations, as investors seek new growth opportunities.
Tips and race-by-race preview for Scone on Tuesday
Everything you need to know to pick a winner on an eight-race card.